You are here: Home → Faculty and Staff → Michael Milam, MD, MPH

Michael Milam, MD, MPH

Gynecologic Oncology

Photo of Dr. Michael Milam

Education:

  • MD, University of Kentucky College of Medicine, Lexington, KY, 1997-2001
  • MPH, University of Texas School of Public Health, Houston, TX, 2005-2007
Internship: Washington University in St. Louis, Barnes – Jewish Medical Center, Obstetrics and Gynecology, 2001-2002

 

Residency: Vanderbilt University, Nashville, TN, Obstetrics and Gynecology, 2002-2005

Fellowship: The University of Texas M.D. Anderson Cancer Center, Houston, TX, Department of Gynecologic Oncology, 2005-2009

Certifications:
American Board of Obstetrics and Gynecology, November 2009

 

Professional Societies: National/International

  • American College of Obstetrics and Gynecology, Junior Fellow (2001)
  • American Society of Clinical Oncologists (2005)
  • Society of Gynecologic Oncologists (2005)
  • American Association of Gynecologic Laparoscopists (2007)
  • Gynecologic Oncology Group (2009)

 

Research Interests:

  • Novel prevention strategies in ovarian and uterine cancer
  • Minimally invasive techniques in gynecological cancer
  • Imaging techniques in gynecological cancer

Honors:

  • 2006-2008 NCI/DHHS/NIH Training of Academic Gynecologic Oncologist Grant (T32-CA101642-01-A2) for Research at MD Anderson Cancer Center
  • 2006 Gynecologic Cancer Foundation/ Eli Lilly Corporation Fellow Award
  • 2007 American Society of Clinical Oncology (ASCO) Foundation Merit Award
  • 2007 Apple Award certificate for excellence in patient education
  • 2009 Amgen Gynecologic Oncology Group Young Investigator Award
  • 2007-2011 National Institute of Health (NIH) Clinical Loan Repayment Program (LRP)

 

Publications

Articles in Peer Reviewed Journals:

Milam MR, Tao X, Coleman RL, Harrell R, Bassett R, dos Reis R, Ramirez PT. Neoadjuvant chemotherapy is associated with prolonged primary treatment intervals in patients with advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2011 21(1):66-71.

Milam MR, Abaid L, dos Reis R, Frumovitz M, Gehrig PA, Livasy C, Broaddus RR, Ramirez PT. Microscopic evaluation of lymph node-bearing tissue in early stage cervical cancer: a dual institution review. Ann Surg Oncol. 2010 17(4):1106-10.

Ramirez PT, Frumovitz M, Milam MR, Deavers M, dos Reis R, Iyer RB, Bhosale P, Schmeler KM. Limited utility of magnetic resonance imaging in determining the primary site of disease in patients with inconclusive endometrial biopsy. Int J Gynecol Cancer. 2010 20(8):1344-9.

Milam MR, Harrell R, Bassett R, Parker LP, Metzinger DS, Ramirez PT. Clinical characteristics of patients with prolonged disease free survival after primary treatment in advanced ovarian cancer: a brief report. Int J Gynecol Cancer. 2010 (In press).

Westin SN, Broaddus RR, Deng L, McCampbell A, Lu KH, Lacour RA, Milam MR, Urbauer DL, Mueller P, Pickar JH, Loose DS. Molecular clustering of endometrial carcinoma based on estrogen-induced gene expression. Cancer Biol Ther. 2009 8(22):2126-35.

Guntupalli SR, Ramirez PT, Anderson ML, Milam MR, Bodurka DC, Malpica A. Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis. Gynecol Oncol. 2009 Jun;113(3):324-6. Epub 2009 Apr 2.

Hobday CD, Milam MR, Milam RA, Euscher E, Brown J. Postoperative small bowel obstruction associated with use of hemostatic agents. J Minim Invasive Gynecol. 2009 Mar-Apr;16(2):224-6.

Suri A, Frumovitz M, Milam MR, dos Reis R, Ramirez PT. Preoperative pathologic findings associated with residual disease at radical hysterectomy in women with stage IA2 cervical cancer. Gynecol Oncol. 2009 Jan;112(1):110-3. Epub 2008 Oct 25.

Frumovitz M, Sun CC, Jhingran A, Schmeler KM, Dos Reis R, Milam MR, Soliman PT, Taylor K, Ramirez PT. Radical hysterectomy in obese and morbidly obese women with cervical cancer. Obstet Gynecol. 2008 Oct;112(4):899-905.

Soliman PT, Bassett RL Jr, Wilson EB, Boyd-Rogers S, Schmeler KM, Milam MR, Gershenson DM, Lu KH. Limited public knowledge of obesity and endometrial cancer risk: what women know. Obstet Gynecol. 2008 Oct;112(4):835-42.

Meyer LA, Westin SN, Lu KH, Milam MR. Genetic polymorphisms and endometrial cancer risk. Expert Rev Anticancer Ther. 2008 Jul; 8(7):1159-67.

Ramirez PT, Schmeler KM, Milam MR, Slomovitz BM, Smith JA, Kavanagh JJ, Deavers M, Levenback C, Coleman RL, Gershenson DM. Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneum. Gynecol Oncol. 2008 Jul; 110(1):56-9. Epub 2008 May 5.

Cole ME, Milam MR, Scott T, Jones 3rd HW. Inadequate Screening in Patients Evaluated by Non-gynecologists for cervical cancer: A Case Control Analysis Am J Obstet Gynecol. 2008 May; 198(5):e48-50. Epub 2008 Mar 14.

Milam MR, Frumovitz M, dos Reis R, Bassett, Jr. RL, Broaddus RR, Ramirez PT:  Preoperative lymph-vascular space invasion is associated with nodal metastases in women with early-stage cervical cancer. Gynecol Oncol. 2007 Jul;106(1):12-5. Epub 2007 May 10.

 

Invited Articles:

Milam MR, Lu KH. Commentary on: Comparison of uterine malignancies that develop during and following tamoxifen therapy [Gynecol Oncol 101:322-326, 2006]. Breast Diseases: A Year Book Quarterly 18(1).

Ramirez PT, Milam MR, Frumovitz M. Laparoscopic extraperitoneal para-aortic lymphadenectomy. Gynecol Oncol. 2007 May 22; [Epub ahead of print].

Lu KH, Milam MR. Gynecologic Cancer Review 2007 – Update on Gynecologic Cancer. OBG Management. July 2007 • Vol. 19, No. 07.

Document Actions
Personal tools